Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.41 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.41 |
| ▸ | AGXT | P21549 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL775451 | 0.88 | LMNA (0.44) | USP2LMNANPSR1KMT2AIDO1 | |
| SCHEMBL15568647 | 0.83 | USP2 (0.44) | USP2LMNANPSR1KMT2AIDO1 | |
| SCHEMBL14426959 | 0.83 | KMT2A (0.43) | USP2LMNANPSR1KMT2ATP53 | |
| SCHEMBL776591 | 0.83 | USP2 (0.41) | USP2LMNANPSR1KMT2AIDO1 | |
| SCHEMBL9421733 | 0.82 | FAAH (0.62) | USP2LMNANPSR1KMT2AIDO1 | |
| SCHEMBL24188595 | 0.81 | SMN1; SMN2 (0.41) | USP2LMNANPSR1KMT2AIDO1 | |
| SCHEMBL1137128 | 0.81 | LMNA (0.47) | USP2LMNANPSR1KMT2ATP53 | |
| SCHEMBL777188 | 0.80 | KMT2A (0.44) | LMNAKMT2AIDO1LOXL2TAAR1 | |
| SCHEMBL486977 | 0.80 | KMT2A (0.44) | USP2LMNANPSR1KMT2AIDO1 | |
| SCHEMBL1259830 | 0.80 | KMT2A (0.44) | USP2LMNANPSR1KMT2AIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115926168-A | Polyether sulphone resin and preparation method thereof | 吉林大学 | 2023-04-07 | — | — | CN | claimed |
| CN-110943253-A | High-voltage lithium ion battery combined electrolyte additive, electrolyte and battery thereof | 松山湖材料实验室 | 2020-03-31 | — | — | CN | claimed |
| EP-1027330-A4 | STYRYL SULFONE ANTICANCER AGENTS | UNIV TEMPLE (US) | 2003-09-10 | — | — | EP | claimed |
| CN-1273580-A | Styryl sulfone anticancer agents | UNIV TEMPLE (US) | 2000-11-15 | — | — | CN | claimed |
| EP-1027330-A1 | STYRYL SULFONE ANTICANCER AGENTS | Temple University of the Commonwealth System of Higher Education (US) | 2000-08-16 | — | — | EP | claimed |
| WO-1999018068-A1 | STYRYL SULFONE ANTICANCER AGENTS | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 1999-04-15 | — | — | WO | claimed |
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| US-11745148-B2 | Functionalized poly(diallylpiperidinium) and its copolymers for use in ion conducting applications | COLORADO SCHOOL OF MINES (US) | 2023-09-05 | — | — | US | disclosed |
| US-11427593-B2 | Bromodomain inhibitor compound and use thereof | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2022-08-30 | — | — | US | disclosed |
| US-20220149436-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-11283107-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-03-22 | — | — | US | disclosed |
| US-20210178340-A1 | FUNCTIONALIZED POLY(DIALLYLPIPERIDINIUM) AND ITS COPOLYMERS FOR USE IN ION CONDUCTING APPLICATIONS | COLORADO SCHOOL OF MINES | 2021-06-17 | — | — | US | disclosed |
| EP-3741758-A1 | BROMODOMAIN INHIBITOR COMPOUND AND USE THEREOF | Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) | 2020-11-25 | — | — | EP | disclosed |
| WO-1991015119-A1 | SUBSTITUTED CYCLOHEXANEDIONES AND THEIR HERBICIDAL USES | DOWELANCO (US) | 1991-10-17 | — | — | WO | disclosed |
| EP-0450711-A1 | Substituted cyclohexanediones and their herbicidal uses | DOWELANCO (US) | 1991-10-09 | — | — | EP | disclosed |
| US-5008369-A | Preparation of polysulfones | EASTMAN KODAK COMPANY (US) | 1991-04-16 | — | — | US | disclosed |
| US-5006159-A | Oximes, effective against grassy weeds but selective to broadleaf crops such as cotton, sugar beets, soybeans, wheat, rice and corn | DOWELANCO (US) | 1991-04-09 | — | — | US | disclosed |
| US-4931530-A | Novel aromatic polyether and a process for producing an ether | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1990-06-05 | — | — | US | disclosed |
| EP-0268112-A2 | A novel aromatic polyether and a process for producing a polyether | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1988-05-25 | — | — | EP | disclosed |
| US-4554381-A | BORON TRIFLUORIDE, HYDROFLUORIC ACID | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1985-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11427593-B2 | Bromodomain inhibitor compound and use thereof | BRD4, BRD1, BRD3 | USP2 2755/4885LMNA 2795/4885NPSR1 4138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.